literal heightpills

Sachlichkeit

Sachlichkeit

blogposting
Joined
May 11, 2025
Posts
354
Reputation
344
infigratinib is a cancer medication that inhibits FGFR1‑FGFR4 signaling.

Infigratinib was studied in the Phase 2 PROPEL 2 trial (NCT04265651), involving 72 children aged 3–11 with achondroplasia. The key findings:
  • Dosages: daily oral doses escalating across cohorts: 0.016, 0.032, 0.064, 0.128, and 0.25 mg/kg. The 0.25 mg/kg/day dose (Cohort 5) was selected for extended treatment reddit.com+10nejm.org+102minutemedicine.com+10.
  • Efficacy: In Cohort 5, the mean increase in annualized height velocity reached +3.03 to +3.38 cm/year at 6 months, stabilizing at +2.50 cm/year by month 18; height z‑scores improved by +0.54 and body proportions also enhanced investors.com+9gimopen.org+9globenewswire.com+9.
  • Side Effects: All participants experienced ≥1 treatment-emergent adverse event (TEAE), mostly mild-to-moderate. The most common included:
Study has shown it is more effective at height increase than vosoritide, which is the go-to for treating achondroplasia. It is also an oral, whereas vosoritide is subq (needle.) It is also cheaper, and easier to get a hold of.

The downside?
  • Infection (who cares.)
  • Diarrhea, constipation
  • Appetite loss
  • Headache
  • Theoretical Alopecia
  • Theoretical Dry eye, blurred vision, REVERSIBLE RETINAL DETACHMENT
  • Theoretical 32% chance of serious adverse effects
  • Theoretical permanent blindness
Theoretical meaning, well, theoretical. So these side effects haven't been observed in trials. Still retarded to risk permanent blindness for height so I will not be using it but interesting nontheless.
 
  • +1
  • Hmm...
  • JFL
Reactions: Bluecod, unon, Miksu7787 and 2 others
how is lyophilized infigratinib administered? Its taken orally in studies
 
Get 3-6cm in exchange of your fucking eyes and serious adverse effects of 32% chance
Sounds like fucking shit to me
 
infigratinib is a cancer medication that inhibits FGFR1‑FGFR4 signaling.

Infigratinib was studied in the Phase 2 PROPEL 2 trial (NCT04265651), involving 72 children aged 3–11 with achondroplasia. The key findings:
  • Dosages: daily oral doses escalating across cohorts: 0.016, 0.032, 0.064, 0.128, and 0.25 mg/kg. The 0.25 mg/kg/day dose (Cohort 5) was selected for extended treatment reddit.com+10nejm.org+102minutemedicine.com+10.
  • Efficacy: In Cohort 5, the mean increase in annualized height velocity reached +3.03 to +3.38 cm/year at 6 months, stabilizing at +2.50 cm/year by month 18; height z‑scores improved by +0.54 and body proportions also enhanced investors.com+9gimopen.org+9globenewswire.com+9.
  • Side Effects: All participants experienced ≥1 treatment-emergent adverse event (TEAE), mostly mild-to-moderate. The most common included:
Study has shown it is more effective at height increase than vosoritide, which is the go-to for treating achondroplasia. It is also an oral, whereas vosoritide is subq (needle.) It is also cheaper, and easier to get a hold of.

The downside?
  • Infection (who cares.)
  • Diarrhea, constipation
  • Appetite loss
  • Headache
  • Theoretical Alopecia
  • Theoretical Dry eye, blurred vision, REVERSIBLE RETINAL DETACHMENT
  • Theoretical 32% chance of serious adverse effects
  • Theoretical permanent blindness
Theoretical meaning, well, theoretical. So these side effects haven't been observed in trials. Still retarded to risk permanent blindness for height so I will not be using it but interesting nontheless.
Are u on this
 
Get 3-6cm in exchange of your fucking eyes and serious adverse effects of 32% chance
Sounds like fucking shit to me
obviously nigga
 

Similar threads

Sachlichkeit
Replies
5
Views
741
AverageCurryEnjoyer
AverageCurryEnjoyer
7evenvox22
Replies
27
Views
2K
Ziov
Ziov
Sachlichkeit
Replies
16
Views
1K
futureashtray
futureashtray
Sphénoïde
Replies
46
Views
4K
vanitycel
vanitycel
Menas
Replies
247
Views
53K
fodenglazer
F

Users who are viewing this thread

Back
Top